These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 648214)

  • 1. Pharmacokinetics of theophylline in hepatic disease.
    Mangione A; Imhoff TE; Lee RV; Shum LY; Jusko WJ
    Chest; 1978 May; 73(5):616-22. PubMed ID: 648214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline disposition in patients with hepatic cirrhosis.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    N Engl J Med; 1977 Jun; 296(26):1495-7. PubMed ID: 865528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline metabolism in patients with hepatosplenic mansoniasis and cirrhosis.
    Cukier A; Strauss E; Terra Filho M; Santos SR; Vargas FS
    J Hepatol; 1992 May; 15(1-2):35-9. PubMed ID: 1506654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline disposition in obesity.
    Gal P; Jusko WJ; Yurchak AM; Franklin BA
    Clin Pharmacol Ther; 1978 Apr; 23(4):438-44. PubMed ID: 630791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cigarette smoking and sex on theophylline disposition.
    Powell JR; Thiercelin JF; Vozeh S; Sansom L; Riegelman S
    Am Rev Respir Dis; 1977 Jul; 116(1):17-23. PubMed ID: 879596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of smoking on theophylline disposition.
    Hunt SN; Jusko WJ; Yurchak AM
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):546-51. PubMed ID: 1277710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral theophylline disposition in cystic fibrosis.
    Georgitis JW; Eigen H; Warner R; Gonzales MA
    Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The theophylline disposition after caffeine administration in liver cirrhosis: an index of liver function.
    Hartleb M; Romańczyk T; Becker A; Mańczyk I; Waluga M; Spalińska M; Zieliński M
    Ital J Gastroenterol; 1992; 24(6):332-7. PubMed ID: 1515659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. System for clinical pharmacokinetic monitoring of theophylline therapy.
    Koup JR; Schentag JJ; Vance JW; Kuritzky PM; Pyszczynski DR; Jusko WJ
    Am J Hosp Pharm; 1976 Sep; 33(9):949-56. PubMed ID: 790952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of theophylline in ten elderly patients.
    Nielsen-Kudsk F; Magnussen I; Jakobsen P
    Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):226-34. PubMed ID: 580350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline disposition in acutely ill hospitalized patients. The effect of smoking, heart failure, severe airway obstruction, and pneumonia.
    Powell JR; Vozeh S; Hopewell P; Costello J; Sheiner LB; Riegelman S
    Am Rev Respir Dis; 1978 Aug; 118(2):229-38. PubMed ID: 697173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markedly prolonged theophylline half-life in liver failure.
    Baselt RC; Albertson TE
    J Anal Toxicol; 1982; 6(2):62-3. PubMed ID: 7098449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cimetidine on the pharmacokinetics of theophylline.
    Schwartz JI; Bachmann KA; Bond LW; Mahajan VK
    Clin Pharm; 1982; 1(6):534-8. PubMed ID: 7185539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and pharmacokinetics in man of orally administered theophylline.
    Nielsen-Kudsk F; Magnussen I; Jensen TS; Naeser K
    Acta Pharmacol Toxicol (Copenh); 1980 Mar; 46(3):205-12. PubMed ID: 7361576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of theophylline in infancy.
    Simons FE; Simons KJ
    J Clin Pharmacol; 1978 Oct; 18(10):472-6. PubMed ID: 711929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline in infants with bronchiolitis.
    Franko TG; Powell DA; Nahata MC
    Eur J Clin Pharmacol; 1982; 23(2):123-7. PubMed ID: 7140801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the surface area of activated charcoal on theophylline clearance.
    Park GD; Spector R; Goldberg MJ; Johnson GF; Feldman R; Quee CK
    J Clin Pharmacol; 1984 Jul; 24(7):289-92. PubMed ID: 6480875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.